| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6158343 | American Journal of Kidney Diseases | 2011 | 8 Pages |
Abstract
This randomized trial is the largest clinical study of a proposed ADPKD intervention to date. It targets patients with ADPKD with early disease who are projected to have rapid cyst growth and accelerated outcomes. Blockade of vasopressin V2 receptor is hypothesized to inhibit cyst growth, thereby delaying additional adverse clinical outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Vicente E. MD, PhD, Esther MD, Kyongtae T. MD, PhD, Arlene B. MD, Olivier MD, PhD, Ron T. MD, PhD, Jared J. MD, Eiji MD, Ronald D. MD, Holly B. MS, John J. PhD, Frank S. MD, PhD,